WuXi AppTec Investor

WuXi AppTec (药明康德) is a global outsourcing company with operations in China and the United States. It provides a broad and integrated portfolio of services throughout the research, development, manufacturing, and regulatory process. WuXi AppTec is also focused on lowering the expense of R&D through efficient outsourcing solutions. The company offers discovery services in the areas of synthetic and medicinal chemistry, analytical chemistry, discovery biology, pharmacology, safety pharmacology, drug metabolism and pharmacokinetics, and bioanalysis; and development services, such as process research and development, research and commercial manufacturing, analytical development, and pharmaceutical development.
Technology: Drug Development
Industry: Precision Medicine
Headquarters: Shanghai, Shanghai, China
Founded Date: Dec 1, 2000
Employees Number: 10001+
Funding Status: IPO
Investor Type: undisclosed
Investment Stage: Undisclosed
Number Of Exits: 2

Visit Website
tech@4abio.com
https://twitter.com/WuXi_AppTec?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor
Register and Claim Ownership